Last reviewed · How we verify
Depakote ER
Depakote ER is a Small molecule drug developed by University of Minnesota. It is currently FDA-approved. Also known as: Divalproex, ABT-711, Depakote Extended Release, divalproex sodium.
Depakote ER is a small molecule medication used to treat conditions such as bipolar disorder, mania, and substance abuse, and is available in a long-acting formulation. It is primarily used to prevent seizures in individuals with absence, partial, and generalized seizures, and as a mood stabilizer in the treatment of bipolar disorder.
At a glance
| Generic name | Depakote ER |
|---|---|
| Also known as | Divalproex, ABT-711, Depakote Extended Release, divalproex sodium |
| Sponsor | University of Minnesota |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma (PHASE2)
- A Study to Investigate Treatment of HU and VPA, or 6-MP and VPA in Unfit AML/HR-MDS Patients (PHASE1, PHASE2)
- Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (APD) Improve Cognition And Psychopathology In Outpatients With Schizophrenia (SCH) Or Schizoaffective Disorder (SAD)? (PHASE4)
- Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca (PHASE1, PHASE2)
- Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy (PHASE2)
- The Role of Dopamine Metabolism in the Antidepressant Effects of Sleep Deprivation and Sertraline in Depressed Patients (PHASE1, PHASE2)
- Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
- Lithium Versus Divalproex for Treating Pediatric Bipolar Disorder (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Depakote ER CI brief — competitive landscape report
- Depakote ER updates RSS · CI watch RSS
- University of Minnesota portfolio CI
Frequently asked questions about Depakote ER
What is Depakote ER?
Who makes Depakote ER?
Is Depakote ER also known as anything else?
What development phase is Depakote ER in?
Related
- Manufacturer: University of Minnesota — full pipeline
- Also known as: Divalproex, ABT-711, Depakote Extended Release, divalproex sodium
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing